Stay updated with breaking news from Priothera ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Kueenburg, former Clinical Development Lead at Celgene, a Bristol Myers Squibb Company, to advance clinical development of mocravimod in Acute Myeloid Leukemia patients undergoing allogeneic
/PRNewswire/ -- Priothera Ltd, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound, mocravimod,...
/PRNewswire/ -- Priothera Ltd, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound, mocravimod,...